Monitoring blood-brain barrier status in a rat model of glioma receiving therapy: dual injection of low-molecular-weight and macromolecular MR contrast media.

Abstract : PURPOSE: To evaluate the sequential injection of a low-molecular-weight (gadoterate meglumine [Gd-DOTA], 0.5 kDa) and a macromolecular (P846, 3.5 kDa) contrast media in monitoring the effect of antitumor therapies (antiangiogenic therapy and/or microbeam radiation therapy [MRT]) on healthy brain tissue and implanted tumors. MATERIALS AND METHODS: Animal use was compliant with official French guidelines and was assessed by the local Internal Evaluation Committee for Animal Welfare and Rights. Eighty male rats bearing 9L gliosarcoma were randomized into four groups: untreated, antiangiogenic (sorafenib) therapy, MRT, and both treatments. Magnetic resonance (MR) imaging was performed 1 day before and 1, 5, and 8 days after the start of the treatment. At all time points, vascular integrity to a macromolecular contrast medium (P846) and, 11 minutes 30 seconds later, to low-molecular-weight contrast medium (Gd-DOTA) was evaluated by using a dynamic contrast material-enhanced MR imaging approach. To quantify vessel wall integrity, areas under the signal intensity curves were computed for each contrast medium. Unpaired t tests and one-way analysis of variance were used for statistical analyses. RESULTS: Tumor vessels receiving antiangiogenic therapy became less permeable to the macromolecular contrast medium, but their permeability to the low-molecular-weight contrast medium remained unchanged. Healthy double-irradiated vessels became permeable to the low-molecular-weight contrast medium but not to the macromolecular contrast medium. CONCLUSION: Antiangiogenic therapy and MRT generate different effects on the extravasation of contrast medium in tumoral and healthy tissues. This study indicates that the use of a low-molecular-weight contrast medium and a macromolecular contrast medium provides complementary information and suggests that the use of two contrast media within the same MR imaging session is feasible.
Type de document :
Article dans une revue
Radiology, Radiological Society of North America, 2010, 257 (2), pp.342-52. 〈10.1148/radiol.10092343〉
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00589222
Contributeur : Michel Dojat <>
Soumis le : samedi 28 avril 2012 - 07:00:11
Dernière modification le : vendredi 28 septembre 2018 - 13:33:10

Fichiers

 Accès restreint
Fichier visible le : jamais

Connectez-vous pour demander l'accès au fichier

  •  Lemasson_2010_Dual_Injection_Auteur.pdf    Visible le : jamais  Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

U836 | UGA

Citation

Benjamin Lemasson, Raphaël Serduc, Cécile Maisin, Audrey Bouchet, Nicolas Coquery, et al.. Monitoring blood-brain barrier status in a rat model of glioma receiving therapy: dual injection of low-molecular-weight and macromolecular MR contrast media.. Radiology, Radiological Society of North America, 2010, 257 (2), pp.342-52. 〈10.1148/radiol.10092343〉. 〈inserm-00589222〉

Partager

Métriques

Consultations de la notice

116